Martin Patrick Murphy
CIK: 0002127581
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IPSC
Century Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Murphy Martin Patrick
Murphy Martin Patrick (SEC CIK 0002127581) files insider reports with the SEC as Director of Century Therapeutics, Inc. (IPSC).
Signal8 holds 3 ownership filings by Murphy Martin Patrick (1 Form 3, 2 Form 4), filed between Apr 10, 2026 and Jun 12, 2026. Those filings report 2 transactions, from Dec 9, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Murphy Martin Patrick's filings is in PHILADELPHIA, PA.
Recent filings by Murphy Martin Patrick
Other insiders filing for Century Therapeutics, Inc. (IPSC)
- Russotti Gregory
- Carr Douglas, SVP Finance & Operations
- Pfeiffenberger Brent, President and CEO
- Truitt Joseph, Director
- Cowan Chad, Chief Scientific Officer
- Riva Alessandro, Director